Key Metrics
CiteScore 

5
Eigenfactor 

0.005 - 0.01
Impact Factor 

< 5
SJR 

Q1Pharmacology (medical)

SNIP 

1.24
Recommended pre-submission checks
Powered by 

Topics Covered on CPT: Pharmacometrics and Systems Pharmacology
CPT: Pharmacometrics and Systems Pharmacology Journal Specifications
Indexed in the following public directories
Web of Science
Scopus
DOAJ
SJR
| Overview | |
| Publisher | WILEY |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 3000 |
| Publication Time | 8 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Society/Institute/Sponsor | American Society for Clinical Pharmacology and Therapeutics (ASCPT) |
| Frequency | Monthly |
| Publication Start Year | 2012 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC, CC BY-NC-ND |
| OA statement | Visit website |
View less
Planning to publish in CPT: Pharmacometrics and Systems Pharmacology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in CPT: Pharmacometrics and Systems Pharmacology
Optimizing Venous Thromboembolism Prophylaxis in Burn Patients Using Enoxaparin Through PBPK Modeling.
- 1 Jun 2026
- CPT: pharmacometrics & systems pharmacology
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles.
- 1 May 2026
- CPT: pharmacometrics & systems pharmacology
Title not available
- 1 May 2026
- CPT: Pharmacometrics & Systems Pharmacology
Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation.
- 1 May 2026
- CPT: pharmacometrics & systems pharmacology
Towards a Quantitative Understanding of Aficamten Clinical Pharmacology: Pharmacokinetic-Cardiodynamic Modeling to Support Safety and Efficacy.
- 1 May 2026
- CPT: pharmacometrics & systems pharmacology
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With Myelofibrosis.
- 1 May 2026
- CPT: pharmacometrics & systems pharmacology
Optimizing Venous Thromboembolism Prophylaxis in Burn Patients Using Enoxaparin Through PBPK Modeling.
- 1 Jun 2026
- CPT: pharmacometrics & systems pharmacology
Machine Learning Meets Pharmacokinetics: A Comparative Analysis of Predictive Models for Plasma Concentration-Time Profiles.
- 1 May 2026
- CPT: pharmacometrics & systems pharmacology
Title not available
- 1 May 2026
- CPT: Pharmacometrics & Systems Pharmacology
Population Pharmacokinetics and Exposure-Response Analysis of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia Patients With NPM1 Mutation.
- 1 May 2026
- CPT: pharmacometrics & systems pharmacology
Towards a Quantitative Understanding of Aficamten Clinical Pharmacology: Pharmacokinetic-Cardiodynamic Modeling to Support Safety and Efficacy.
- 1 May 2026
- CPT: pharmacometrics & systems pharmacology
Semi-Mechanistic PK/PD Modeling of Platelets and Spleen Volume With Navitoclax in Combination With Ruxolitinib in Patients With Myelofibrosis.
- 1 May 2026
- CPT: pharmacometrics & systems pharmacology